Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,077 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer

NCT05355298

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • GenesisCare St Leonards, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Gallipolli Medical Research Foundation Greenslopes, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

NCT01081262

Conditions
Adnexal Diseases, Borderline Ovarian Mucinous Tumor, Endocrine Gland Neoplasms, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 248 locations
View Trial Details
Active, Not Recruiting

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

NCT06619236

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Arizona Center for Cancer Care (ACCC) - Biltmore Scottsdale, Arizona, United States
  • University of Arizona Cancer Center - Research and Administration at Main Campus Tucson, Arizona, United States
  • Providence Saint Joseph Medical Center - Roy and Patricia Disney Family Cancer Center Burbank, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

NCT03737643

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
Locations
  • Research Site Foothill Ranch, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site San Francisco, California, United States
View all 214 locations
View Trial Details

Related conditions